DK2906578T3 - Hidtil ukendte flavonoidforbindelser og anvendelser deraf - Google Patents

Hidtil ukendte flavonoidforbindelser og anvendelser deraf Download PDF

Info

Publication number
DK2906578T3
DK2906578T3 DK13846070.4T DK13846070T DK2906578T3 DK 2906578 T3 DK2906578 T3 DK 2906578T3 DK 13846070 T DK13846070 T DK 13846070T DK 2906578 T3 DK2906578 T3 DK 2906578T3
Authority
DK
Denmark
Prior art keywords
flavonoid
unknown
connections
unknown flavonoid
flavonoid connections
Prior art date
Application number
DK13846070.4T
Other languages
English (en)
Inventor
Grant Andrew Mclachlan
Original Assignee
Armaron Bio Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2012904444A external-priority patent/AU2012904444A0/en
Application filed by Armaron Bio Pty Ltd filed Critical Armaron Bio Pty Ltd
Application granted granted Critical
Publication of DK2906578T3 publication Critical patent/DK2906578T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/26—Acyclic or carbocyclic radicals, substituted by hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/06—Benzopyran radicals
    • C07H17/065—Benzo[b]pyrans
    • C07H17/07—Benzo[b]pyran-4-ones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/26—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
    • C07D311/28—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only
    • C07D311/30—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only not hydrogenated in the hetero ring, e.g. flavones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pulmonology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Toxicology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK13846070.4T 2012-10-11 2013-10-11 Hidtil ukendte flavonoidforbindelser og anvendelser deraf DK2906578T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2012904444A AU2012904444A0 (en) 2012-10-11 Novel Flavonoid compounds and uses thereof
PCT/AU2013/001175 WO2014056038A1 (en) 2012-10-11 2013-10-11 Novel flavonoid compounds and uses thereof

Publications (1)

Publication Number Publication Date
DK2906578T3 true DK2906578T3 (da) 2019-07-15

Family

ID=50476785

Family Applications (1)

Application Number Title Priority Date Filing Date
DK13846070.4T DK2906578T3 (da) 2012-10-11 2013-10-11 Hidtil ukendte flavonoidforbindelser og anvendelser deraf

Country Status (17)

Country Link
US (1) US10316053B2 (da)
EP (1) EP2906578B8 (da)
JP (2) JP6567419B2 (da)
KR (1) KR102169002B1 (da)
CN (2) CN104955831A (da)
AU (1) AU2013330222B2 (da)
BR (1) BR112015008156A2 (da)
CA (1) CA2887488C (da)
DK (1) DK2906578T3 (da)
ES (1) ES2730926T3 (da)
MX (1) MX368855B (da)
NZ (1) NZ707087A (da)
RU (1) RU2647842C2 (da)
SG (1) SG11201502758SA (da)
TR (1) TR201908822T4 (da)
WO (1) WO2014056038A1 (da)
ZA (1) ZA201502703B (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111233806A (zh) * 2020-03-20 2020-06-05 武汉轻工大学 一种3,5,4＇-三乙酰氧基-7-羟基黄酮的制备方法
CN112168976B (zh) * 2020-10-15 2022-11-04 天津科技大学 一种黄酮衍生物前药及合成和作为抗肿瘤药物的应用
CN115504970B (zh) * 2022-10-18 2023-04-18 黑龙江中医药大学 一种用于治疗心肌缺血的黄酮类衍生物及其制备方法

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06161129A (ja) * 1992-11-25 1994-06-07 Mita Ind Co Ltd 電子写真感光体
JP2003504327A (ja) * 1999-07-08 2003-02-04 プレンダーガスト、パトリック、ティ． 感染症の治療を目的としたフラボン類、クマリン類および関連化合物の使用
WO2001021608A2 (en) * 1999-09-23 2001-03-29 Vereniging Voor Christelijk Wetenschappelijk Onderwijs Novel flavonoids
JP2003019867A (ja) * 2001-04-19 2003-01-21 Mitsubishi Chemicals Corp 光記録媒体
GB0125532D0 (en) * 2001-10-24 2001-12-12 Burton Michael Enzyme activity indicators
WO2006030322A2 (en) * 2004-09-17 2006-03-23 University Of Manitoba Use of fla vone/fla vanone derivatives fn the treatment or prevention of respiratory conditions
US20060084615A1 (en) * 2004-10-20 2006-04-20 Chan Albert S Puerarin derivatives and their medical uses
CA2601028C (en) 2005-03-11 2014-05-27 Howard Florey Institute Of Experimental Physiology And Medecine Flavonoid compounds and uses thereof
JP2007230145A (ja) * 2006-03-02 2007-09-13 Mitsubishi Chemicals Corp 光学記録媒体の記録層形成用色素、及びそれを用いた光学記録媒体、その光学記録媒体の記録方法
WO2008011538A2 (en) * 2006-07-19 2008-01-24 The Salk Institute For Biological Studies Methods of using flavonoids to enhance memory
US7863323B1 (en) * 2006-10-27 2011-01-04 The University Of Melbourne Flavonols
DE102008012909A1 (de) 2008-03-06 2009-09-10 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verwendung von Flavonoidverbindungen für die Prophylaxe und Therapie ischämischer oder entzündlicher Herz- und Kreislauferkrankungen
CN101244057B (zh) * 2008-03-11 2010-06-02 中国人民解放军第二军医大学 具有降血脂作用的3-取代氧基-3',4'-二甲氧基黄酮类化合物
JP5424296B2 (ja) * 2008-08-28 2014-02-26 静岡県公立大学法人 フラボン誘導体の製造方法およびシアル酸転移酵素阻害剤
EP2424541A2 (en) * 2009-04-27 2012-03-07 Limerick BioPharma, Inc. Phosphorylated and phosphonated pyrone analogs for therapeutic treatment
JP2012044944A (ja) * 2010-08-27 2012-03-08 Railway Technical Research Institute トルエン検出方法
DE102011104441A1 (de) * 2011-06-16 2012-12-20 Fujitsu Technology Solutions Intellectual Property Gmbh Schaltnetzteil, Betriebsverfahren und Verwendung eines Schaltnetzteils in einem Computer
WO2013020184A1 (en) * 2011-08-11 2013-02-14 Neuprotect Pty Ltd Flavonoid compounds, and methods of use thereof
CN102631362B (zh) * 2012-01-19 2013-04-24 中国人民解放军第二军医大学 射干异黄酮类化合物在制备预防和治疗紫外线致皮肤损伤药物中的应用
CN102617672B (zh) * 2012-02-24 2014-03-12 大连大学 一种金花茶黄酮苷及其制备方法和用途
CN102697768A (zh) * 2012-06-07 2012-10-03 中国人民解放军第二军医大学 一类木犀草素类似黄酮类化合物在制备抗肿瘤药物中的用途
TR201809001T4 (tr) * 2012-10-02 2018-07-23 Sphingotec Gmbh Böbrek fonksiyonunu teşhis etmek veya izlemek veya böbrek fonksiyonu bozukluğunu teşhis etmek için bir usul.

Also Published As

Publication number Publication date
AU2013330222A1 (en) 2015-05-21
ES2730926T3 (es) 2019-11-13
ZA201502703B (en) 2016-11-30
MX2015004578A (es) 2016-03-04
EP2906578B8 (en) 2019-06-26
SG11201502758SA (en) 2015-05-28
EP2906578A4 (en) 2016-03-23
KR20150096376A (ko) 2015-08-24
RU2647842C2 (ru) 2018-03-21
TR201908822T4 (tr) 2019-07-22
KR102169002B1 (ko) 2020-10-23
CN104955831A (zh) 2015-09-30
JP6567419B2 (ja) 2019-08-28
RU2015117641A (ru) 2016-11-27
BR112015008156A2 (pt) 2017-07-04
JP2018184414A (ja) 2018-11-22
CA2887488C (en) 2020-07-14
US20150259373A1 (en) 2015-09-17
AU2013330222B2 (en) 2016-05-12
MX368855B (es) 2019-10-18
EP2906578B1 (en) 2019-05-08
WO2014056038A1 (en) 2014-04-17
JP2015533128A (ja) 2015-11-19
EP2906578A1 (en) 2015-08-19
CA2887488A1 (en) 2014-04-17
US10316053B2 (en) 2019-06-11
CN107759553A (zh) 2018-03-06
NZ707087A (en) 2016-04-29

Similar Documents

Publication Publication Date Title
DK3043784T3 (da) Arylethere og anvendelser deraf
DK2914291T3 (da) Anti-komplement-c1s-antistoffer og anvendelser deraf
DK3035936T3 (da) Visse kemiske enheder, sammensætninger og fremgangsmåder
DK2850202T3 (da) Fremgangsmåder og grupper
BR112014032116A2 (pt) método.
DK2986726T3 (da) Hidtil ukendte bacillusstammesammensætninger
DK2962100T3 (da) Tuberkulosebiomarkører og anvendelser deraf
DK2917181T3 (da) Heteroarylderivater og anvendelser deraf
BR112015013892A2 (pt) simulador.
DK3453723T3 (da) Anti-ASIC1-antistoffer og anvendelser deraf
DK2975030T3 (da) Dihydropyridazin-3,5-dion-derivat
DK2618842T3 (da) Hidtil ukendt immunstimulerende fremgangsmåde
DK2877736T3 (da) Skrue, skruedel og fremgangsmåde dertil
FR2986872B1 (fr) .
DK2805954T3 (da) 7-substitueret hanfangichin b-derivat, og fremstillingsfremgangsmåde og anvendelse deraf
DK2943460T3 (da) 6-chlor-3-(phenyl-d5)-inden-1-on og anvendelse deraf
BR112015001416A2 (pt) plugue.
DK2888100T3 (da) Fremstillingsfremgangsmåde, fremstillingsform og anvendelse
BR112014028444A2 (pt) dispositivo refratário, e, tampão de purga.
DK2906578T3 (da) Hidtil ukendte flavonoidforbindelser og anvendelser deraf
DK3003298T3 (da) Antifibrogene forbindelser, fremgangsmåder og anvendelser deraf
BR112014027645A2 (pt) 5-halogenopirazol bifenilcarboxamidas.
BR112015013877A2 (pt) método, e, composição
FR2993389B1 (fr) Antifusible
BR302012005406S1 (pt) Configuração aplicada em candelabro.